Search Kailos website

Pharmacogenetics is the study of how your genes affect the way your body reacts to and processes medication. Kailos Genetics’ InspexionTM pharmacogenetic test targets several key genes responsible for processing a host of medications commonly prescribed to treat conditions such as chronic pain, cancer, high cholesterol, schizophrenia, and many other illnesses. Knowing specific variations in your genes can help your doctor personalize your healthcare and choose which medications and dosages will work best for your unique physiology.

July 6, 2020

Colon cancer is the third most common cancer diagnosed in the United States, with the exclusion of skin cancers. The lifetime risk of disease development is 4.1% for women and 4.4% for men. Despite the disease’s prevalence, many people are unaware of the symptoms of colon cancer and whether or not the disease is hereditary, or can run in families. Here, we describe colon cancer, including its symptoms, causes and therapies, and the prevalence of and gene mutations associated with hereditary forms of the disease.

June 2, 2020

You’ve seen it in the news. Or maybe you’ve heard about it from friends, family or your patients. Or maybe you have a loved one that was recently diagnosed with cancer. Hereditary cancer screening is at the forefront of medical technology and is revolutionizing healthcare by unlocking information coded in your genes. But is it something that would help you, your family or your patients? Below, we’ve compiled some common reasons people undergo hereditary cancer screening to help you determine whether or not screening is the right option for you.

Lynch syndrome is a heritable cancer syndrome caused by variations in genes that are responsible for repairing errors in DNA. People with Lynch syndrome are at higher risk for developing many types of cancer, including cancers of the colon, rectum, stomach, small bowel, ovaries and the uterus.

As a healthcare provider, you have likely encountered a patient requesting a commercially-available laboratory test to assist in diagnosing a particular disease.  Over the past several years, clinical laboratory testing has emerged as one of the fastest growing segments of healthcare, and while a significant portion of this market is composed of hospital labs, independent labs make up a major portion of this market in the United States.  Some commercially-available clinical tests are marketed to patients with severe and disabling symptoms and include inflated claims regarding the clinical utility of the tests.  It can be difficult for...

June 21, 2020

Companies such as Ancestry and 23andMe, which sell novelty DNA ancestry tests for genealogy research, are now promoting the ability of their tests to detect hereditary cancer genes.  Hereditary cancer genes are altered genes that increase an individual’s risk of developing cancer and are inherited by a child from their parent, usually resulting in a family history of cancer.  While the convenience of being able to screen your DNA for hereditary cancer genes while learning about your genealogy may at first sound appealing, hereditary cancer screenings performed by clinical labs versus ancestry testing companies are not the same...